Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Similar documents
Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

INTRODUCTION TO PHARMACOKINETICS

Principles of Drug Action. Intro to Pharmacology: Principles of Courework Drug Action Intro to Pharmacology

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Industrial Toxicology

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Unit 2b: EXCRETION OF DRUGS. Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK)

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Principles of Pharmacology. Pharmacokinetics & Pharmacodynamics. Mr. D.Raju, M.pharm, Lecturer PHL-358-PHARMACOLOGY AND THERAPEUTICS-I

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Introduction to Pharmacokinetics

DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA

Pharmacodynamics & Pharmacokinetics 1

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

SEIZURES PHARMACOLOGY. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration

Pharmacokinetics. Karim Rafaat

Introduction pharmacology and drug administration

Brand and Generic Drugs. Educational Objectives. Absorption

Drug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)

Tala Saleh. Abdul Aziz ALShamali. Abdul Aziz ALShamali

Pharmacokinetics: The Basics

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

AROMASIN 25mg (Tablets)

DEFINITIONS. Pharmacokinetics. Pharmacodynamics. The process by which a drug is absorbed, distributed, metabolized and eliminated by the body

Fundamentals of Pharmacology for Veterinary Technicians Chapter 4

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

Pharmacokinetic Phase

B. Incorrect! Compounds are made more polar, to increase their excretion.

Renal Excretion of Drugs

General Principles of Pharmacology and Toxicology

PHARMACOLOGY-1 PHL-313. Ali Alhoshani Office: 2B 84

Farmadol. Paracetamol 10 mg/ml INFUSION SOLUTION

PHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004

Basic Concepts of TDM

Chapter : Sources and Bodily Effect of Drugs

Section 5.2: Pharmacokinetic properties

Routes of drug administration

Introducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building

BASIC PHARMACOKINETICS

Metabolism Paracetamol is metabolised in the liver and excreted in the urine mainly as glucuronide and sulphate conjugates.

Chapter 4. Drug Biotransformation

Pharmacokinetics in the critically ill. Intensive Care Training Program Radboud University Medical Centre Nijmegen

One-Compartment Open Model: Intravenous Bolus Administration:

Pharmacokinetic Phase

TDM. Measurement techniques used to determine cyclosporine level include:

BIOPHARMACEUTICS and CLINICAL PHARMACY

Nonlinear Pharmacokinetics

METABOLISM. Ali Alhoshani, B.Pharm, Ph.D. Office: 2B 84

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

Metabolism. Objectives. Metabolism. 26 July Chapter 28 1

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

Pharmacokinetics Metabolism

Chapter Questions. Modern Pharmacology With Clinical Applications. Sixth Edition

Toxicant Disposition and Metabolism. Jan Chambers Center for Environmental Health Sciences College of Veterinary Medicine

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

Biopharmaceutics. Tips Worth Tweeting. Contributor: Sandra Earle

Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University

Determination of bioavailability

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

NANO 243/CENG 207 Course Use Only

Medication Administration. By: Carolyn McCune RN, BSN, MSN, CRNP

Click to edit Master title style

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

General Pharmacology

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Pharmacology med term exam

VENOUS THROMBOEMBOLISM PHARMACOLOGY. University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

Metabolic Changes of Drugs and Related Organic Compounds

Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology

M0BCore Safety Profile

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

MTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride

TOXICOKINETICS; DISPOSITION OF XENOBIOTICS (Absorption, Distribution and Excretion of xenobiotics)

PRESCRIBING IN LIVER AND RENAL DISEASE

Principles of Toxicology: The Study of Poisons

Pharmacotherapy Issues in the Pediatric Population

PHA5128 Dose Optimization II Case Study I Spring 2013

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11

COMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

PHARMACOKINETICS SMALL GROUP I:

Composition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:

ENVIRONMENTAL TOXICOLOGY

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Transcription:

Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

2 Learning objectives Understand compartment models and how they effects drug concentrations Understand the two main parameters of pharmacokinetics (Vd and Cl) Understand ADME and the characteristics of each Know how to estimate how much drug remains after X hours after administrations Compare and contrast the 2 phases of metabolism Understand how enzyme inhibition and induction work as well as how that effects drugs and prodrugs Know the sites of drug excretion/elimination Know the key Plasma level and dose terms Know the parameters of variability in drug action Differentiate between an allergy and intolerance

3 Pharmacokinetics What is pharmacokinetics The study of the absorption, distribution, metabolism, and eliminations of drugs with respect to time (ADME) Two main parameters Volume of distribution Clearance 3 rd parameter half life

4 Volume of distribution (Vd) Vd is a theoretical space measured in liters Average blood volume = 3 liters Vd could be greater than 3 liters, how? 50 mg of drug in your body 5 mg in the blood Vd = 10 L

5 Volume of distribution (Vd) Factors Increasing Vd Lipophilic drugs Decreased plasma protein binding Increased tissue binding Factors Decreasing Vd Hydrophilic drugs Increased plasma protein binding Decreased tissue binding

6 Compartment Models One compartment models Plasma Highly perfused organs Liver & kidneys Two compartment models Peripheral tissues Central Compartment Elimination Peripheral Compartment

7

8 Clearance Clearance: Portion of the drug removed from the volume of distribution per unit time (L/hr) Mechanisms for clearance (can be a combination) Renal elimination Hepatic metabolism Biliary excretion

9 Clearance factors that effect Rates Absorption rates IV fast Oral slow Rectal - sporadic Distribution rates Compartment models 1 vs. 2 Metabolism rates Biotransformation, or metabolites Elimination rates Involves 2 variables: drug concentration and time Elimination rate = -dc/dt

10 Elimination rates Rates of elimination First order The amount of drug removed over time changes The fraction of drug removed remains constant. Concentration dependent Half-life Zero order Higher concentration = higher rate of removal Lower concentration = lower rate of removal Amount of time for the drug concentration to decrease by ½ in the volume of distribution 100 mg of drug x was given. Drug x has a half life of 2 hours. In 6 hours how many mgs of drug x would be remaining? Amount of drug removed per unit time remains the same Fraction of drug removed decreases Concentration independent Concept of half-life does not apply Mixed order

11 Elimination rates Zero order Amount of drug removed per unit time remains the same Fraction of drug removed decreases Concentration independent Concept of half-life does not apply Mixed order When enzymes play a role in elimination Mixture of first order elimination and zero order First order, enzyme saturation, Zero order

12 ADME finally! Absorption Distribution Metabolism Excretion

13 Absorption Absorption: Transfer of drug from the site of administration to systemic circulation Administration Enteral: Through digestive system Parenteral: Straight into the vasculature Topical: Through the skin, tissues, or membranes Accomplished only AFTER drug makes it to systemic circulation

14 Absorption - Enteral route of administration Through the GI tract tablets, capsules, suspensions, solutions & suppositories All swallowed Oral medications Sublingual Rectal Heart Sublingual Liver GI Tract Rectal

15 Absorption - Parenteral route of administration Directly into systemic circulation any administration other than enteral IV IM IA SC Intrathecal Intrasynovial Intraosseus Intraperitoneal Liver Heart GI Tract All parenteral medications

16 Absorption - Topical route of administration Directly onto the skin or tissue that is exposed to an area outside the body liquids, powders, creams, ointments, gels, sprays patches Transdermal Ophthalmic Vaginal Intrauterine Transmucosal nasal (not orally) Heart All transdermal medications Liver GI Tract

17 Absorption - Make sure you know. Inhalation Heart Liver GI Tract

18 Absorption - Bioavailability 1 Enteral 2 Liver Heart GI Tract Parenteral Depends on: ROA Drug characteristics The body 3 Topical

19 Absorption - Bioavailability ROA First pass metabolism Hydrophilicity vs. lipophilicity Current GI conditions Food vs. empty stomach ph Enzymes availability GI motility Drug Characteristics Hydrophilicity vs. lipophilicity Dosage form pka The Body ph Blood flow Enzymes

20 Absorption - First Pass Effect Can effect orally administered drugs by up to 90% and more Potency? Using a non-oral route and dosage form can help Costly Wrong drug characteristics Drug design can help prodrugs A drug that must undergo first pass metabolism before the active drug compound/molecule is released

21 Distribution Distribution Relocation of the drug from the systemic circulation to its site of action Movement between compartments Exit the vasculature Peripheral Compartment

22 Distribution Distribution depends on: Size of the drug molecule Lipid solubility Drug pka and the tissue/blood ph Perfusion to site of action Binding of plasma proteins

23 Distribution more on plasma proteins

24 Distribution highly protein bound drugs (>90%) Drugs > than 90% protein bound May be displaced Toxic effects Displacing drug may interfere with clearance Reduced number of plasma proteins Toxic effects

25 Break time

26 Learning objectives Understand compartment models and how they effects drug concentrations Understand the two main parameters of pharmacokinetics (Vd and Cl) Understand ADME and the characteristics of each Know how to estimate how much drug remains after X hours after administrations Compare and contrast the 2 phases of metabolism Understand how enzyme inhibition and induction work as well as how that effects drugs and prodrugs Know the sites of drug excretion/elimination Know the key Plasma level and dose terms Know the parameters of variability in drug action Differentiate between an allergy and intolerance

27 Metabolism Metabolism: The process of chemically inactivating a drug by converting it into a more water-soluble compound or metabolite that can then be excreted from the body. Two phases

28 Metabolism Phase 1 metabolism Make a drug more water soluble by altering the molecule Reactions of Oxidation Hydrolysis Reduction GER!

29 Metabolism Phase 2 (conjugation) Make a drug more water soluble by combining it with another molecule Union of a drug with a more water soluble substance Glycine Methyl Alkyl Glucuronide Endoplasmic Reticulum Enzyme notice ASE.

30 Metabolism CYP450 Metabolism of most lipid soluble drugs Cytochrome P 450 isoenzyme family 3A4 2C9 2C19 2D6 1A2 Important terms Substrate Inducer Inhibitor

31 Metabolism Enzyme inhibition/induction Drug Administered at the same Drug time Substrate Inducer Inhibitor Concentration 1 X Decreased 2 X Normal Drug Administered at the same Drug time Substrate Inducer Inhibitor Concentration 1 X Increased 2 X Normal Patients won t experience benefit Patients might experience toxicity Drug Administered at the same Drug time Substrate Inducer Inhibitor Concentration 1 X Slight Decrease 2 X Slight Decrease

32 Metabolism Enzyme inhibitors/inducers Major Inhibitors - GPACMAN Grapefruit juice Protease inhibitors Amiodarone Cimetidine Macrolide Abx Aromatase inhibitors Non-dihydropyridine CCBs Major Inducers - PSPORCS Phenytoin Smoking Phenobarbital Oxcarbazepine Rifampin Carbamazepine St. John s Wort

33 Metabolism enzyme induction/inhibition What happens to drug concentrations of drug X if it is a substrate for isoenzyme 2C9 but that particular enzyme is saturated (no available enzyme binding sites)? What is an active metabolite? What is an inactive metabolite?

34 Excretion Excretion: The process by which drugs are removed from the body.

35 Excretion- Kidney Most important elimination route Percent Unchanged Free/unbound/water soluble pka and the ph of the urine Weak base drug excreted in acidic urine Vitamin C Weak acid drug excreted in alkaline urine Sodium bicarbonate Blocking sites of excretion Probenecid to block the tubular excretion of penicillin

36 Excretion - Lungs Volatile liquids or gas Increased pulmonary blood flow Increase excretion in the lungs Decreased pulmonary blood flow Decreased excretion Breathalyzer test

37 Excretion GI tract Biliary excretion Liver, bile, duodenum, to feces Enterohepatic recycling Fat soluble substances

38 Excretion Sweat/salivary/mammary glands Relatively unimportant part of excretion Sweat and salivary Tend to cause adverse effects Bad taste Skin reactions Mammary glands Drug in breast milk Basic compounds

39 Plasma level and dose Terms Duration of action Half-life Minimal effective concentration Onset of action Peak plasma level Steady state Termination of action Therapeutic range Toxic level

40 Variability in drug action Average adult dose is based on a drug quantity that produces a certain effect in 50% of the population between age 18-65 and weigh 150 lbs. Age Children Elderly Gender Water & naïve metabolic systems Less muscle, more fat, & warn out body systems Women Men More fat& smaller size Pregnant More muscle mass & larger size Genetics Fast acetylators Non functional enzymes

41 Drug allergy Allergy 2 nd exposure Immunes system medicated Anaphylaxis Sensitivity/intolerance Nausea Diarrhea Headache. Bronchospasm, hypotension, & death Autoimmune response Thrombocytopenia Anemia Angioedema, arthralgia, & fever Inflammatory reactions Skin rash

42 Questions